Top

High Blood Pressure & Cardiovascular Prevention

Published in:

01-07-2008 | Contributions from International Congress

11.2 The Appropriate Drugs Titration and the Optimization of the Therapy in Chronic Heart Failure (CHF): the Outcomes in our Experience of Home TelemonItoring (HTM)

Authors: L. Beltrami, M. Benvenuto, C. Redaelli, D. Solari, G. Rossetti, S. Pizzocri, S. Carugo

Published in: High Blood Pressure & Cardiovascular Prevention | Issue 3/2008

Excerpt

Introduction. The primary end-points of the treatment of CHF are the reduction of mortality, morbidity and hospitalization and the improvement of the quality of life of the patient. However, many clinical trials showed an underuse of the drugs recommended by the Guidelines, with a displacement in favour of diuretics, nitrates and digoxin and an inferior prescription of beta-blockers, antialdosterone drugs, ACE-inhibitors (ACEI) and angiotensin II receptor blockers (ARBs). We sought if home telemonitoring was able to optimize the therapy of patients with CHF and to improve their compliance and quality of life. …

Title: 11.2 The Appropriate Drugs Titration and the Optimization of the Therapy in Chronic Heart Failure (CHF): the Outcomes in our Experience of Home TelemonItoring (HTM)
Authors: L. Beltrami
M. Benvenuto
C. Redaelli
D. Solari
G. Rossetti
S. Pizzocri
S. Carugo
Publication date: 01-07-2008
Publisher: Springer International Publishing
Published in: High Blood Pressure & Cardiovascular Prevention / Issue 3/2008
Print ISSN: 1120-9879
Electronic ISSN: 1179-1985
DOI: https://doi.org/10.1007/BF03263710

Keynote webinar | Spotlight on medication adherence

Springer Medicine

11.2 The Appropriate Drugs Titration and the Optimization of the Therapy in Chronic Heart Failure (CHF): the Outcomes in our Experience of Home TelemonItoring (HTM)

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2008

Is C-Reactive Protein a Reliable Risk Factor of Cardiovascular Morbidity and Mortality in Clinical Practice?

12.22 Sedentary Blood Pressure Variability is Associated with the Microvascular Damage in Normotensive Subjects

9.5 Impact of Antihypertensive Treatment on Long-Term Risk of Diabetes Mellitus in a General Population Setting: Data from the PAMELA Study

6.5 Silent Pheochromocytoma Presenting as Tako-Tsubo Syndrome during Anaesthesiological Stress

The Clinical Significance of Blood Pressure Lowering Treatment: First-Line Drug Choice is Important

4.7 Heritability of Plasma Lipoprotein-Associated Phospholipase A2 (Lp-PLA2): a New Marker of Cardiovascular Risk